新云社 reports: Sellas Life Sciences shares opened up 220% after the drug developer said Tuesday its experimental vaccine for a blood cancer produced positive late-stage clinical trial results, significantly extending patients’ survival time. The opening surge was reported by market data platform MSX.COM.
Sellas Life Sciences Shares Jump 220% on Positive Late-Stage Vaccine Data
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
15m ago
Nvidia market cap falls $2.7T in six weeks as tech selloff deepens
42m ago
Strategy’s Bitcoin Paper Loss Deepens as BTC Trades Below $55,500
56m ago
Credo and Astera Labs shares drop over 10% in broad US market selloff
1h ago
Bitdeer mined and sold 281.1 BTC in week to Nov 20, keeps zero holdings
1h ago
Morgan Stanley Adds Nearly 800 BTC, Bitcoin Ahr999 Index Falls Below 3.12 Low
2h ago
Morgan Stanley Adds 799 BTC via MSBT, Total Holdings Reach 12,448 BTC




